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Abstract The 1-n-propoxy-3-methyl-3-phospholene 1-oxide was prepared in optically active 
form by extending our resolution methods applying (−)-(4R,5R)-4,5-
bis(diphenylhydroxymethyl)-2,2-dimethyldioxolane (“TADDOL”), (−)-(2R,3R)-α,α,α',α'-
tetraphenyl-1,4-dioxaspiro[4.5]decan-2,3-dimethanol (“spiro-TADDOL”), as well as the 
acidic and neutral Ca
2+
 salts of (−)-O,O’-dibenzoyl- and (−)-O,O’-di-p-toluoyl-(2R,3R)-
tartaric acid. In one case, the diastereomeric complex could be identified by single crystal X-
ray analysis. The absolute P-configuration of the enantiomers of the phospholene oxide was 
also determined by CD spectoroscopy. 
Keywords: Alkoxy-3-phospholene 1-oxide; P-chirality; Resolution methods; Optical isomers; 
X-ray crystallography; CD-spectroscopy; Absolute P-configuration 
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1. Introduction 
 Chiral organophosphorus compounds, especially the ones having an asymmetric centre on 
phosphorous atom form an interesting group, as the transition metal complexes incorporating 
the corresponding P(III)-derivatives may be potential catalysts in a wide variety of 
homogenous catalytic reactions.
1-3
 
 Several reviews and book chapters have been published on the preparation of 
organophosphorus compounds in optically active form. These papers discuss different 
methods to obtain P-stereogenic compounds in enantiopure form, including the resolution of 
the corresponding racemic compounds via the formation of covalent diastereomers, 
diastereomeric salts, transition metal complexes and molecular complexes.
4-6
 According to 
these methods described in the literature, O,O’-dibenzoyl-(2R,3R)-tartaric acid,7-15 
bromocamphorsulfonic acid,
16-18
 camphorsulfonic acid,
18
 mandelic acid,
19,20
 2,2’-dihydroxy-
1,1’-binaphthalene19,21 and α-methylbenzylamine22 can be used to prepare secondary and or 
tertiary phosphine-oxides in optically active form via the formation of molecular complexes, 
but none of these methods have found widespread application. In the sphere of chiral P-
heterocycles, Pietrusiewicz and his co-workers reported several special methods for the 
preparation of the enantiomers of 2- and 3-phospholene 1-oxides and their fused 
derivatives.
23-26
 
 In the last few years, our research group has developed efficient resolution methods for 
five- and six-membered P-heterocycles including 3-phospholene oxides, a 
phosphabicyclo[3.1.0]hexane oxide, a dihydro- and a tetrahydrophosphinine oxide via 
diastereomeric complex formation with TADDOL derivatives (2 and 3), and the Ca
2+
 salts of 
O,O’-dibenzoyl- and O,O’-di-p-toluoyl-(2R,3R)-tartaric acid (4–7).27-32 
 In this paper, we describe the resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide 
(1) using the methods developed in our research group (Fig. 1). The absolute configuration of 
the P-chiral center of the enantiomers of 3-phospholene oxide 1 was also identified.  
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Figure 1. The 1-n-propoxy-3-methyl-3-phospholene oxide (1) and resolving agents [(−)-2-
(−)-7] used in this study. 
 
2. Results and discussion 
2.1. Resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) with TADDOL derivatives 
[(−)-2 and (−)-3] 
 Following the resolution method developed in our research group,
27,28
 the resolution of 1-
n-propoxy-3-methyl-3-phospholene 1-oxide (1) was attempted first with TADDOL 
derivatives [(−)-2 and (−)-3] in a mixture of ethyl acetate and hexane. The mixture of racemic 
3-phospholene 1-oxide (1) and TADDOL or spiro-TADDOL [(−)-2 or (−)-3, respectively] 
was dissolved in hot ethyl acetate, and the corresponding diastereomeric complex precipitated 
after the addition of hexane to the mixture. 
 Previously, it was found that the efficiency of the resolutions of the aryl-, alkyl- and 
alkoxy-substituted-3-phosphole oxides with TADDOL derivatives [(−)-2 and (−)-3] may be 
influenced by changing the solvent.
33
 Hence, the resolution of the 3-phospholene oxide (1) 
with TADDOL derivatives [(−)-2 or (−)-3] was also attempted using methanol, ethanol and 
isopropyl alcohol as the solvent. In these instances, the mixture of the racemic 3-phospholene 
oxide (1) and TADDOL derivatives [(−)-2 or (−)-3] was dissolved in hot alcohol, and 
crystalline diastereomeric complex appeared by cooling down the mixture to 26 °C (Scheme 
1). In case of all resolution experiments, the half equivalent methodology
34
 was followed, 
hence, considering the composition of the diastereomeric complexes, 0.5-1 equivalents of the 
resolving agents [(−)-2 or (−)-3] were used. Results of the successful resolutions leading to 
crystalline diastereomers are summarized in Table 1. 
 In all cases, the diastereomers formed were crystallized for 3 hours, and then they were 
filtered off from the mother liquors. The diastereomeric complexes were purified further by 
two recrystallizations from the corresponding solvents. The 3-phospholene oxide (1) was 
recovered from the corresponding diastereomer by column chromatography using silica gel 
and 3% of methanol in dichloromethane as the eluent. 
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Scheme 1. General resolution procedure for racemic 3-phospholene oxide (1) using 
TADDOL derivatives [(−)-2 and (−)-3]. 
 
 The composition of the diastereomers was determined by 
1
H NMR. It depended on the 
resolving agent [(−)-2 or (−)-3] and the solvent used. Diastereomers were obtained mainly in 
a ratio of 1:1, but using spiro-TADDOL [(−)-3] in ethanol a 1:2 diastereomeric complex of 
1∙[(−)-3]2 was also formed (Table 1).  
 The diastereomeric complexes obtained were analysed by chiral GC after regenerating the 
3-phospholene oxide (1) from the sample of the corresponding diastereomer by preparative 
TLC using silica gel and 3% of methanol in dichloromethane as eluent. After crystallization, 
the enantiomeric excess values were in the range of 40–77%. The enantiomeric purity 
increased significantly after two recrystallizations, when enantiomeric excess values of 87–
99% had been achieved (Table 1).  
 It was found that the resolving agent [(−)-2 or (−)-3] and the solvent used influence which 
of the 3-phospholene oxide (1) enantiomers was incorporated in the diastereomeric complex. 
The combination of the resolving agent [(−)-2 or (−)-3] and the solvent had also an impact on 
the efficiency of the resolutions. Both TADDOL [(−)-2] and spiro-TADDOL [(−)-3] in a 
mixture of ethyl acetate and hexane were found to be efficient resolving agents for n-propoxy-
phospholene oxide (1) (S = 0.38 and 0.40, respectively), however, the application of 
TADDOL [(−)-2] provided a higher enantiomeric excess (ee > 99%) (Table 1, entries 1 and 
2). Generally, a decrease in resolving capability (S) was observed, when different alcohols 
were used as the solvent instead of a mixture of ethyl acetate and hexane. We were not 
successful when TADDOL [(−)-2] was used in alcohols, as no diastereomeric complexes 
were formed in these instances.  
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 It is noteworthy that the use of spiro-TADDOL [(−)-3] in ethanol led to diastereomeric 
complex formation with (S)-1-n-propoxy-3-methyl-3-phospholene 1-oxide [(S)-1], while the 
other enantiomer [(R)-1] was involved in all other instances (Table 1, entries 3 vs. 1-2 and 4). 
 
Table 1. Resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) with TADDOL 
derivatives [(−)-2 and (−)-3] 
Entry 
Resolving  
agent 
Eq. Solvents
a
 
Diastereomer 
complex
b
 
Yield
c,f
 
(%) 
ee
d,f
 
(%) 
S
e,f
 
(-) 
Abs. 
Config.
g
 
1 TADDOL 0.5 2×EtOAc/10×hexane (1)(TADDOL) 
(63) 
38 
(77) 
>99 
(0.48) 
0.38 
(R) 
2 spiro-TADDOL 0.5 2×EtOAc/10×hexane (1)(spiro-TADDOL) 
(72) 
43 
(54) 
93 
(0.39) 
0.40 
(R) 
3 spiro-TADDOL 1 6×EtOH (1)(spiro-TADDOL)2 
(76) 
15 
(40) 
93 
(0.30) 
0.14 
(S) 
4 spiro-TADDOL 0.5 6×iPrOH (1)(spiro-TADDOL) 
(67) 
10 
(55) 
87 
(0.37) 
0.08 
(R) 
a
Mixture of solvents for the crystallization and recrystallizations [mL of solvent/g of resolving agent]. 
b
The ratio of 1 and (−)-2 or (−)-3 was determined by 1H NMR. 
c
Based on the half of the racemate 1 that is regarded to be 100% for each antipode. 
d
Determined by chiral GC. 
e
Resolving capability, also known as the Fogassy parameter (S = Yield × ee).35 
f
Results obtained after the first crystallization are shown in parantheses, while results obtained after two 
recrystallizations are shown in boldface. 
g
The absolute configuration of 1 was determined by X-Ray analysis and CD spectroscopy. 
 
 The phenomena that TADDOL derivatives [(−)-2 or (−)-3] may form diastereomeric 
complexes with both antipodes of the 3-phospholene oxides (1) in different solvents allowed 
us to develop a resolution procedure to obtain both enantiomers from racemic 1-n-propoxy-3-
methyl-3-phospholene 1-oxide (1). 
 Both enantiomers of the 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) were prepared 
by exploiting the different antipode preference of TADDOL [(−)-2] in ethyl acetate – hexane 
and that of the spiro-TADDOL [(−)-3] in ethanol. At first, the racemic n-propoxy-
phospholene oxide (1) was resolved with 0.5 equivalent of TADDOL [(−)-2] in a mixture of 
ethyl acetate and hexane. The diastereomer [(−)-1]∙[(−)-2] was purified by two 
recrystallizations, and (−)-(R)-1-n-propoxy-3-methyl-3-phospholene 1-oxide [(−)-(R)-1] was 
recovered by column chromatography with an ee > 99% and in a yield of 38%. The combined 
mother liquors of the crystallization and recrystallization were purified by column 
chromatography to afford (+)-(S)-1 with an ee of 23% and a yield of 97%. The crystallization 
of this enantiomeric mixture with 1.23 equivalent of spiro-TADDOL [(−)-3] in ethanol 
afforded the diastereomeric complex [(−)-1]∙[(−)-3]2, that was purified by two 
recrystallizations to obtain (+)-(S)-1-n-propoxy-3-methyl-3-phospholene 1-oxide [(+)-(S)-1] 
6 
with an ee of 96% and in a yield of 15% after decomplexation by column chromatography 
(Scheme 2). 
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Scheme 2. The complete resolution process of 1-n-propoxy-3-methyl-3-phospholene 1-oxide 
(1) with TADDOL and spiro-TADDOL [(−)-2 and (−)-3]. 
 
2.2. Resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) with calcium hydrogen 
(−)-O,O’-dibenzoyl- or (−)-O,O’-di-p-toluoyl-(2R,3R)-tartrate [(−)-4 or (−)-5] 
 The resolution of the 3-phospholene oxide (1) was also attempted using the acidic Ca
2+
-
salts of the (−)-O,O’-dibenzoyl- or (−)-O,O’-di-p-toluoyl-(2R,3R)-tartaric acid [(−)-4 or (−)-
5]. The results are summarized in Table 2.  
 Similarly to our earlier studies, Ca(H-DBTA)2 [(−)-4] was prepared as a stable 
reagent,
29,30
 while Ca(H-DPTTA)2 [(−)-5] was always prepared in situ by reacting (−)-O,O’-
di-p-toluoyl-(2R,3R)-tartaric acid with CaO in a 10:1 mixture of ethanol and water. The 
racemic 3-phospholene oxide (1) in ethanol, ethyl acetate or acetonitrile was added to the hot 
ethanolic solution of 0.25 equivalents of Ca(H-DBTA)2 or Ca(H-DPTTA)2 [(−)-4 or (−)-5]. 
The crystalline diastereomers having the composition of Ca(1)2(H-DBTA)2 or Ca(1)2(H-
DPTTA)2 were filtrated off after 24 hours of crystallization. These diastereomers [Ca(1)2(H-
DBTA)2 or Ca(1)2(H-DPTTA)2] were purified by two digestions (i.e., stirring the crystals in 
the corresponding solvent at 26 °C for 24 hours). The 3-phospholene oxide (1) was recovered 
by treating the dichloromethane solution of the corresponding complex Ca(1)2(H-DBTA)2 or 
7 
Ca(1)2(H-DPTTA)2 with 10% aqueous ammonia (Scheme 3). The enantiomeric excess of the 
3-phospholene enantiomers (1) was determined by chiral GC. 
 
P
O OnPr
Me
+ 0.25 eq.
solvent*
P
O OnPr
Me
+
()-4 ()-51 1[()-4] [()-5][1]2 [1]2
P
O OnPr
Me
2
H O(O)CAr
HOOC COO
HArC(O)OCa2+
2
Ar =
H O(O)CAr
HOOC COO
HArC(O)OCa
2+
2
or
Ph p-MePh
or
Precipitate Solution
* See Table 2.  
Scheme 3. General resolution procedure for racemic 3-phospholene oxide (1) using  
Ca(H-DBTA)2 or Ca(H-DPTTA)2 [(−)-4 or (−)-5]. 
 
 Using Ca(H-DBTA)2 [(−)-4] as resolving agent, the nature of the enantiomer of the 3-
phospholene oxide (1) incorporated in the diastereomeric complex Ca(1)2(H-DBTA)2 
depended on the solvent used. Resolution of racemic n-propoxy-3-phospholene oxide (1) with 
Ca(H-DBTA)2 [(−)-4] in ethanol, or in a mixture of ethyl acetate and ethanol afforded (S)-n-
propoxy-3-phospholene oxide [(S)-1], while the other enantiomer (R)-1 could be obtained 
using a mixture of acetonitrile and ethanol as the solvent (Table 2, entries 1–3). Using Ca(H-
DPTTA)2 [(−)-5], the (R)-n-propoxy-3-phospholene oxide [(R)-1] could be prepared in all 
solvents used (Table 2, entries 4–6). 
 The highest ee and resolving capability (S) values obtained with Ca(H-DBTA)2 or Ca(H-
DPTTA)2 [(−)-4 or (−)-5] were 59% and 0.20, respectively, after purification by two 
digestions (Table 2, entries 3 and 4). The application of Ca(H-DPTTA)2 [(−)-5] led to higher 
resolving capability values than that of Ca(H-DBTA)2 [(−)-4] (Compare Table 2, entries 1–3 
and 4–6). 
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Table 2. Resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) with 0.25 equivalent 
of Ca(H-DBTA)2 or Ca(H-DPTTA)2 [(−)-4 or (−)-5] 
Entry Resolving agent Solvents
a
 Diastereomer complex
b
 
Yield
c,f
 
(%) 
ee
d,f
 
(%) 
S
e,f
 
(-) 
Abs. 
Config.
g
 
1 Ca(H-DBTA)2 3×EtOAc/3×EtOH Ca(1)2(H-DBTA)2 
(80) 
34 
(17) 
17 
(0.14) 
0.06 
(S) 
2 Ca(H-DBTA)2 6×EtOH Ca(1)2(H-DBTA)2 
(60) 
7 
(18) 
22 
(0.11) 
0.02 
(S) 
3 Ca(H-DBTA)2 3×MeCN/3×EtOH Ca(1)2(H-DBTA)2 
(73) 
18 
(11) 
59 
(0.08) 
0.11 
(R) 
4 Ca(H-DPTTA)2 3×EtOAc/3×EtOH/10%H2O Ca(1)2(H-DPTTA)2 
(65) 
36 
(41) 
55 
(0.26) 
0.20 
(R) 
5 Ca(H-DPTTA)2 6×EtOH/10%H2O Ca(1)2(H-DPTTA)2 
(66) 
35 
(44) 
47 
(0.29) 
0.17 
(R) 
6 Ca(H-DPTTA)2 3×MeCN/3×EtOH/10%H2O Ca(1)2(H-DPTTA)2 
(69) 
30 
(46) 
56 
(0.31) 
0.17 
(R) 
See Table 1 for footnotes. 
 
2.3. Resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) with calcium (−)-O,O’-
dibenzoyl- and (−)-O,O’-di-p-toluoyl-(2R,3R)-tartrate [(−)-6 and (−)-7] 
 The resolution of n-propoxy-3-phospholene oxide (1) was also attempted with the neutral 
Ca
2+
 salts of (−)-O,O’-dibenzoyl- and (−)-O,O’-di-p-toluoyl-(2R,3R)-tartaric acid [(−)-6 and 
(−)-7], respectively, as these resolving agents were also found suitable for the resolution of 
some 3-phospholene oxides previously.
30
 Successful experiments resulting in crystalline 
diastereomers are summarized in Table 3. 
 Ca(DBTA) and Ca(DPTTA) [(−)-6 and (−)-7], respectively were prepared in situ by the 
reaction of CaO and (−)-O,O’-dibenzoyl- or (−)-O,O’-di-p-toluoyl-(2R,3R)-tartaric acid 
having 1:1 ratio in a mixture of ethanol and water. To this solution was added the racemic 3-
phospholene oxide (1) in ethanol, ethyl acetate or acetonitrile. The crystalline diastereomers 
formed were filtrated off after 24 hours. The diastereomers were purified by digestions 
(Scheme 4). In a few cases, only one purification was applied, as in certain cases the 
corresponding diastereomeric complex dissolved completely during the second digestion 
(Table 3, entries 1-3). 
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Scheme 4. General resolution procedure for racemic 3-phospholene oxides (1) using 
CaDBTA or CaDPTTA [(−)-6 or (−)-7]. 
 
 In all but one instances, the ratio of the 3-phospholene oxide (1) and CaDBTA or 
CaDPTTA [(−)-6 or (−)-7], determined by 1H NMR, was 1:1 (Table 3, entries 1-4 and 6), the 
exception was a diastereomer with a stoichiometry of 1:2 (Table 3, entry 5). With CaDBTA 
[(−)-6] as the resolving agent, both enantiomers of n-propoxy-3-phospholene oxide (1) could 
be prepared using different solvent mixtures, while the resolutions with CaDPTTA [(−)-7] 
afforded exclusively the (R)-n-propoxy-3-phospholene oxide [(R)-1] (Table 3). 
 Using CaDBTA and CaDPTTA [(−)-6 and (−)-7], the resolving capability (S) was in the 
range of 0.01-0.10 after purification, what is lower than the values obtained with the 
corresponding acidic Ca
2+
 salts [(−)-4 and (−)-5] (Compare Tables 2 and 3). As the 
enantiomeric excess values were in the same range with the acidic and the neutral Ca
2+
 salts 
of the (−)-O,O’-dibenzoyl- or (−)-O,O’-di-p-toluoyl-(2R,3R)-tartaric acid [(−)-4 – (−)-7], 
respectively (17–59% and 16-62%, respectively), the difference in resolving capability (S) 
may be explained by the lower yields (2–17%) obtained with CaDBTA [(−)-6] and CaDPTTA 
[(−)-7].  
 Considering the enantiomeric excess and the resolving capability (S), the application of 
TADDOL derivatives [(−)-2 or (−)-3] seems more advantageous, as compared to the acidic 
and neutral salts of DBTA and DPTTA [(−)-4 – (−)-7]. However, the application of the Ca(H-
DBTA)2 [(−)-4] and Ca(H-DPTTA)2 [(−)-5] may seem more favourable when the price 
difference between (−)-O,O’-dibenzoyl- or (−)-O,O’-di-p-toluoyl-(2R,3R)-tartaric acid and 
the TADDOL derivatives [(−)-2 and (−)-3] is considered. Moreover, the decomposition of the 
diastereomeric complexes of the Ca(H-DBTA)2 and Ca(H-DPTTA)2 [(−)-4 and (−)-5] is 
simpler, than that of the TADDOL derivatives [(−)-2 and (−)-3] (extraction versus column 
chromatography). 
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Table 3. Resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) with Ca(DBTA) or 
Ca(DPTTA) [(−)-6 or (−)-7] 
Entry 
Resolving 
agent 
Eq. Solvents
a
 
Diastereomer 
complex
b
 
Yield
c,f
 
(%) 
ee
d,f
 
(%) 
S
e,f
 
(-) 
Abs. 
Config.
g
 
1 CaDBTA 0.5 3×EtOAc/3×EtOH/10%H2O Ca(1)(DBTA) 
(31) 
5
*
 
(17) 
17
*
 
(0.05) 
0.01
*
 
(S) 
2 CaDBTA 0.5 6×EtOH/10%H2O Ca(1)(DBTA) 
(32) 
2
*
 
(15) 
16
*
 
(0.05) 
0.01
*
 
(S) 
3 CaDBTA 0.5 3×MeCN/3×EtOH/10%H2O Ca(1)(DBTA) 
(33) 
3
*
 
(39) 
62
*
 
(0.13) 
0.02
*
 
(R) 
4 CaDPTTA 0.5 3×EtOAc/3×EtOH/10%H2O Ca(1)(DPTTA) 
(73) 
14 
(59) 
59 
(0.43) 
0.08 
(R) 
5 CaDPTTA 1 6×EtOH/10%H2O Ca2(1)(DPTTA)2 
(43) 
17 
(57) 
61 
(0.25) 
0.10 
(R) 
6 CaDPTTA 0.5 3×MeCN/3×EtOH/10%H2O Ca(1)(DPTTA) 
(33) 
11 
(59) 
59 
(0.20) 
0.07 
(R) 
See Table 1 for footnotes. 
* Diastereomeric complex was purified with one recrystallization. 
 
2.4. Single crystal X-ray analysis of diastereomeric complex [Ca(1)2(H-DPTTA)2] 
 Results from the crystal structure determination (Fig. 2) apart from revealing the 
respective molecular structures as well as absolute configurations also give an insight into 
some aspects of molecular recognition. Disorder phenomenon is especially obvious for the 
Ca
2+
 - salt system [Ca(1)2(H-DPTTA)2] (c.f. Fig. 3). The disordered propoxy-chain indicates 
alternating conformations of this component of the guest molecule. This fact indicates that the 
phospholene rings do keep some intrinsic pseudo-rotatory ability. It also gives an indication 
as to the origin of the relative low scattering power from such crystals.  
The diastereomeric salt associate including phospholene oxide 1 (Fig. 2) also shows a similar 
binding type, as described in an analogous crystal structure.
29
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Figure 2. Perspective view of the crystallographic asymmetric unit of the Ca
2+
:1:H-DPTTA 
1:2:2 system. For the sake of clarity all H atoms were omitted from the drawing, thin lines 
indicate the coordinative bonds from and to the Ca
2+
 cation. Disorder atomic sites are visible 
at the propoxy side chain, as well as some alternating atomic sites for some puckered ring C-
atoms. 
 Ca
2+
 ions acting as the primary binding tool fuse these associated molecules into an 
endless catena- structure in the solid state. The coordination sphere around the metal ion is 
like as it was in the acidic Ca
2+
 salt of dibenzoyl-tartaric acid,
29
 albeit phospholene guests 
differ both in size and ramification. The coordination sphere is octahedral in both cases, and 
the shortest distances, i.e. strongest interactions, occur between similar moieties of the host 
and guest. From inspecting packing features, it is also visible that the voids, filled by the 
target phospholene-oxide molecules are well-suited for enabling variable positions for the 
alkoxy-tails from the chiral P-centre (Fig. 3). Apolar p-toluoyl moieties of the H-DPTTA host 
are directed outwards in the crystals such that only feeble contacts are possible from this 
environment to the non-O atoms of the phospholene oxide derivative (1). All these features 
are largely similar to the dibenzoyl - tartaric acid host system
29
 underlining the basic 
recognition motifs in the crystalline state being affected by the metal coordination, supported 
and assisted by the tartaric acid framework. Thus one could perhaps rightly assume that the 
Ca-tartaric acid hemi-salts alike behaviour attests a synthon-like feature. 
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Figure 3. Packing motif from the crystal structure of the Ca
2+
:1:H-DPTTA 1:2:2 system. For 
the sake of clarity all H atoms are omitted from the drawing. 
 
2.5. CD spectra of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) 
 The UV absorption and CD spectra of the 1-n-propoxy-3-methyl-3-phospholene 1-oxide 
(1) were recorded (Table 4) and analyzed. To facilitate the assignment of the absolute 
configuration of the title compound (1), DFT (density functional theory) quantum chemical 
calculations were performed using the PBE0 functional and the 6-311++G** basis set.. 
 
Table 4. Observed UV and CD spectral bands of 1-n-propoxy-3-methyl-3-phospholene 1-
oxide (1) 
  
UV spectra CD spectra 
λ [nm] ε [dm3mol–1cm–1] λ [nm] Δε [dm3mol–1cm–1] 
1-n-propoxy-3-methyl-3-phospholene 1-
oxide (1) 
191 6100   
219 (sh) 400 222 1,9 
   243 –0,5 
 
 In the calculations a simplified model compound, 1-methoxy-3-methyl-3-phospholene 1-
oxide (Fig. 4.) was considered as a model for 1-n-propoxy-3-methyl-3-phospholene 1-oxide 
(1). This simplification results in significant savings in computation time, but it is not 
expected to influence the assignment of the absolute configuration, as the UV-visible and CD 
13 
spectra of the compounds are almost independent of the alkyl-groups connected to the oxygen 
atom. This is justified by the good agreement of the spectra measured in this study and the 
spectra of alkoxy-substituted-phospholene-derivatives considered in our previous papers.
28
 
 
 
Figure 4. DFT-optimized geometry for the most stable conformer of 1-methoxy-3-methyl-3-
phospholene 1-oxide. Characteristic bond lengths (in Å) and angles (in degree) are as follows: 
P1-O1 1.495, P1-C1 1.827, C1-C2 1.502, C2-C3 1.339, C3-C4 1.491, C3-C5 1.509, C5-P1 
1.817, P1-O2 1.622, C1-P1-C5 97, O1-P1-O2 114, O1-P1-O2-C6 52, O1-P1-C1-C2 138. 
 
 First, a systematic conformation analysis was carried out for the model molecule. 
Three conformers were found differing in the position of the methoxy-group. Two of them are 
practically isoenergetic, and the third one lies at about 4 kJ/mol above the first two ones. The 
geometries for all of the three conformers were optimized, and excitation energies, as well as 
oscillator and rotator strengths were computed.  
 The optimized geometry of the most stable conformer is displayed in Fig. 4, while the 
calculated and measured spectra are presented in Fig. 5. The agreement of the measured and 
computed absorption spectra of the compounds is good and justifies the selection of the 
theoretical model employed. The sign of the dominant features in the experimental and 
theoretical CD spectra are identical, which means that the absolute configuration of the 
synthesized compounds is identical to that of the enantiomer considered in the calculations. 
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Figure 5. The calculated (dashed line) UV absorption (a) and CD (b) spectra of (R)-1-
methoxy-3-methyl-3-phospholene 1-oxide together with the measured (solid line) spectra of 
(−)-1-n-propoxy-3-methyl-3-phospholene 1-oxide [(−)-1]. 
 
3. Conclusions 
 Resolution procedures were developed for 1-n-propoxy-3-methyl-3-phospholene 1-oxide 
(1) using TADDOL derivatives [(−)-2 and (−)-3], as well as acidic and neutral Ca2+ salts of 
(−)-O,O’-dibenzoyl- or (−)-O,O’-di-p-toluoyl-(2R,3R)-tartaric acid [(−)-4 – (−)-7]. It was 
found that the solvent used had a significant effect on the efficiency of the resolutions. Both 
antipodes of 1-n-propoxy-3-phospholene 1-oxide (1) were prepared with an ee > 96% by 
exploiting the different antipode preference of the TADDOL derivatives [(−)-2 and (−)-3]. 
 The absolute configuration of the enantiomers of 3-phospholene oxide 1 was determined 
by CD spectroscopy, using TD-DFT quantum chemical calculations for the analysis of the 
spectra, as well as X-ray crystallography. The X-ray crystallographic measurement also 
revealed the interactions between resolving agent Ca(H-DPTTA)2 [(−)-5] and the 3-
phospholene oxide 1. 
 
4. Experimental 
4.1. General 
 The 
31
P and 
1
H NMR spectra were taken on a Bruker AV-300 or DRX-500 spectrometer 
operating at 121.5 and 300 or 202.4 and 500 MHz, respectively.  
 The enantiomeric excess (ee) values of the 3-phospholene oxide 1 were determined by 
chiral GC on Agilent 4890D instrument equipped with a Supelco BETA DEX
TM
 120 column 
(30 m × 0.25 mm, 0.25 µm film, FID detector, nitrogen as carrier gas, injector 240 °C, 
detector 300 °C, head pressure: 10 psi, at 1:100 split ratio). Retention times of 1 by chiral GC 
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(program: 2 min at 140 °C, 5 °C/min to 190 °C, then kept at 190 °C): 13.95 min for (S)-1 and 
14.14 min for (R)-1.  
 Optical rotations were determined on a Perkin-Elmer 241 polarimeter.  
 The 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1),
36
 (−)-(4R,5R)-4,5-
bis(diphenylhydroxymethyl)-2,2-dimethyldioxolane [(−)-2], the (–)-(2R,3R)-α,α,α’,α’-
tetraphenyl-1,4-dioxaspiro[4.5]decan-2,3-dimethanol [(−)-3]37 and the calcium hydrogen (−)-
O,O’-dibezoyl-(2R,3R)-tartrate [(−)-4]29 were synthesized as described earlier. The (−)-O,O’-
dibezoyl- and the (–)-O,O’-di-p-toluoyl-(2R,3R)-tartaric acid was purchased from Aldrich 
Chemical Co. 
 
4.2. Resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) with TADDOL [(−)-2] 
(Representative Procedure A) 
 1.7 g (9.6 mmol) of racemic 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) and 2.2 g 
(4.8 mmol) of TADDOL [(−)-2] was dissolved in 4.4 mL of hot ethyl acetate, and then 22 mL 
of hexane was added. Colourless crystalline diastereomeric complex (R)-1∙TADDOL 
appeared immediately. After standing at 26 °C for 3 h, the crystals were separated by 
filtration to give 1.9 g (63%) of (R)-1∙TADDOL with a de of 77%. The diastereomeric 
complex (R)-1∙TADDOL was purified further by two recrystallizations from a mixture of 4.4 
mL of ethyl acetate and 22 mL of hexane to afford 1.3 g (43%) of the complex (R)-
1∙TADDOL with a de above 99%. The (R)-1-n-propoxy-3-methyl-3-phospholene 1-oxide 
[(R)-1] was recovered from the diastereomer by column chromatography (silica gel, 
dichloromethane:methanol 97:3) to give 0.32 g (38%) of phospholene oxide (R)-1 with an ee 
above 99%.  25D  = −14.6 (c 2.2, CHCl3) (Table 2, entry 1). 
 
4.3. Resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) with sprio-TADDOL  
[(−)-3] 
 1-n-propoxy-3-phospholene oxide (1) was resolved with spiro-TADDOL [(−)-3] 
according to the Representative Procedure A. When the resolutions were carried out in 
methanol, ethanol or isopropyl alcohol, the racemic 3-phospholene oxide (1) and the spiro-
TADDOL [(−)-3] were dissolved in hot alcohol, and the corresponding diastereomeric 
complexes precipitated by cooling down the mixture to 26 °C. The conditions and the results 
are shown in Table 1.  
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4.4. Resolution of 1- n-propoxy-3-methyl-3-phospholene 1-oxide (1) with calcium hydrogen 
O,O’-dibenzoyl-(2R,3R)-tartrate [(−)-4] (Representative Procedure B) 
 To 0.19 g (0.24 mmol) of Ca(H-DBTA)2∙(H2O)2 [(−)-4∙(H2O)2] in 0.56 mL of hot ethanol 
was added 0.17 g (0.95 mmol) of racemic 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) 
in 0.56 mL of acetonitrile. After the addition, the solution was allowed to cool down to 26 °C, 
whereupon colourless crystals appeared. After standing at 26 °C for 24 h, the crystals were 
filtered off to give 0.19 g (73%) of Ca[((R)-1)2(H-DBTA)2] with a de of 11%. The 
diastereomeric complex was purified further by two digestions, by stirring the suspension of 
the diastereomeric complex at 26 °C in a mixture of 0.56 mL of ethanol, 0.56 mL of 
acetonitrile for 24 h to afford 0.062 g (24%) of Ca[((R)-1)2(H-DBTA)2] with a de of 59%. The 
phospholene oxide (R)-1 was recovered from the diastereomeric complex by treatment of the 
2 mL dichloromethane solution of the Ca[((R)-1)2(H-DBTA)2] with 2 mL of a 10% aqueous 
ammonia. The organic layer was washed with 0.5 mL of water, dried (Na2SO4), and 
concentrated to give 0.015 g (18%) of (R)-1-n-propoxy-3-methyl-3-phospholene 1-oxide [(R)-
1)] with an ee of 59%. Resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) with 
Ca(H-DBTA)2 [(−)-4] was also performed in a mixture of ethanol and ethyl acetate, or in 
ethanol. The conditions and the results are shown in Table 2, entries 1-3. 
 
4.5. Resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) with calcium hydrogen 
O,O’-di-p-toluoyl-(2R,3R)-tartrate [(−)-5] (Representative Procedure C) 
 To 0.21 g (0.52 mmol) of DPTTA∙H2O in a mixture of 0.63 mL of ethanol and 0.06 mL of 
water was added 0.014 g (0.26 mmol) of CaO, and the mixture was heated at the boiling point 
until it became clear. 0.18 g (1.0 mmol) of racemic 1-n-propoxy-3-methyl-3-phospholene 1-
oxide (1) in 0.63 mL of ethyl acetate was then added to the solution of the in situ formed 
resolving agent Ca(H-DPTTA)2 [(−)-5]. After the addition, the solution was allowed to cool 
down to 26 °C, whereupon colourless crystals appeared. After standing at 26 °C for 24 h, the 
crystals were filtered off to give 0.19 g (65%) of Ca[((R)-1)2(H-DPTTA)2] with a de of 41%. 
The diastereomeric complex was purified further by two digestions, by stirring the suspension 
of the diastereomeric complex at 26 °C for 24 h in a mixture of 0.63 mL of ethanol, 0.63 mL 
of ethyl acetate and 0.06 mL of water to afford 0.13 g (42%) Ca[((R)-1)2(H-DPTTA)2] with a 
de of 55%. The phospholene oxide (R)-1 was recovered by treatment of the 2 mL 
dichloromethane solution of the complex with 2 mL of 10% aqueous ammonia. The organic 
phase was washed with 0.5 mL of water, dried (Na2SO4), and concentrated to give 0.032 g 
(36%) of (R)-1-n-propoxy-3-methyl-3-phospholene 1-oxide [(R)-1] with an ee of 55%. The 
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resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) with Ca(H-DPTTA)2 [(−)-5] 
was accomplished in a mixture of ethanol and water, or in a mixture of ethanol, water and 
acetonitrile. The conditions and the results are shown in Table 2, entries 4-6. 
 
4.6. The resolution of 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) with calcium O,O’-di-
benzoyl-(2R,3R)-tartrate and calcium O,O’-di-p-toluoyl-(2R,3R)-tartrate [(−)-6 and (−)-7] 
 1-n-propoxy-3-phospholene oxide (1) was resolved with Ca(DBTA) and Ca(DPTTA) 
[(−)-6 and (−)-7] according to Representative Procedure C. When Ca(DBTA) and 
Ca(DPTTA) [(−)-6 and (−)-7] were used as resolving agents, the ratio of CaO and DBTA or 
DPTTA was 1:1. The conditions and the results are shown in Table 3. 
 
4.7. The complete resolution process for 1-n-propoxy-3-methyl-3-phospholene 1-oxide (1) 
with TADDOL derivatives [(−)-2 and (−)-3] 
 The resolution of 1.7g (9.6 mmol) of racemic 1-n-propoxy-3-methyl-3-phospholene 1-
oxide (1) was performed with 2.2 g (4.8 mmol) of TADDOL [(−)-2] in a mixture of 4.4 mL of 
ethyl acetate and 22 mL of hexane as described in Representative Procedure A. 0.32 g (38%) 
of (R)-1-n-propoxy-3-methyl-3-phospholene 1-oxide [(R)-1] was obtained in an ee above 99% 
after two recrystallizations and decomposition of the diastereomeric complex with column 
chromatography (silica gel, dichloromethane:methanol 97:3). The mother liquors of the 
crystallization and recrystallizations were combined and purified by column chromatography 
(silica gel, dicholomethane:methanol 97:3) to give 0.81 g (97%) of (S)-1 in an ee of 23%. To 
this enantiomeric mixture, 2.9 g (5.7 mmol) of spiro-TADDOL [(−)-3] was added, and the 
resolution was elaborated in 17 mL of ethanol according to Representative Procedure A. The 
diastereomeric complex (S)-1∙(spiro-TADDOL)2 was purified by two recrystallizations from 
17 mL of ethanol, and 0.13 g (15%) of (S)-1-n-propoxy-3-methyl-3-phospholene 1-oxide [(S)-
1] was obtained in an ee of 96% after the decomposition of the diastereomeric complex by 
column chromatography (silica gel, dichloromethane:methanol 97:3). 
 
4.8. X-ray measurements 
 X-ray quality crystals of the diastereomeric complex Ca
2+
:1:H-DPTTA 1:2:2 were grown 
from a saturated methanol solution of 3.1 mg (0,018 mmol) of (R)-1 and 3.6 mg (0.0045 
mmol) of Ca(H-DPTTA)2 prepared in situ as described in Representative Procedure C. 
 A selected single crystal colourless, prism, (0.35 × 0.55 × 0.55 mm) of Ca(1)2(H-
DPTTA)2 was mounted on a Rigaku R-AXIS RAPID diffractometer (graphite 
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monochromator Cu-Kα radiation, λ = 1.54178 Å). Data collection was performed at ambient 
temperatures (T = 295(2) K). Crystal data for Ca(1)2(H-DPTTA)2:C54H64CaO20P2, 
monoclinic, space group C2, a = 30.6520(6)Å, b = 7.6583(1)Å, c = 13.7082(3)Å, b = 
109.356(1), V = 3036.0(1) Å3, T = 295(2) K, Z = 2, Dx = 1.268 Mg/m
3, µ = 1.991 mm–1. 
Initial structure model was obtained by SHELXS-97,
38
 completed by successive difference 
Fourier syntheses and refined to convergence by SHELXL-97,
38
 R
1
 = 0.0456 and wR
2
 = 
0.1117 for 3330 [I>2σ( I)] and R1 = 0.0604 and wR2 = 0.1369 for all (3869) intensity data. 
Refined absolute structure parameter x = 0.011(16).
39
 
 Crystallographic data for Ca(1)2(H-DBTA)2 have been deposited at the Cambridge 
Crystallographic Data centre under deposition number CCDC 965084. Copies of these data 
can be obtained free of charge upon application to CCDC, 12 Union Road, Cambridge CB2 
1EZ, UK (fax: 00 44 (0) 1223 336033 or e-mail: deposit@ccdc.cam.ac.uk). 
 
4.9. CD measurements 
 The UV absorption and CD spectra were measured in acetonitrile solution. The UV 
spectra were recorded on an Agilent 8453 diode array spectrometer, the CD spectra were 
obtained with a Jasco J-810 spectropolarimeter. 
 
4.10. Theoretical calculations 
 The quantum chemical calculations were carried out at the density functional theory 
(DFT) level using the PBE0
40
 functional and the 6-311++G** basis set. For the calculation of 
the absorption and CD spectra the time-dependent DFT method
41,42
 was invoked. Rotator 
strengths were calculated in the velocity gauge. The calculations were performed using the 
polarized continuum model
43
 with acetonitrile as the solvent since the experimental spectra 
were measured in the latter. The theoretical calculations were performed by the Gaussian 09 
package.
44
 
 The theoretical UV absorption (CD) curves for each conformer were obtained as 
superpositions of Gaussian functions placed at the wavelengths of the computed transitions 
with heights proportional to the corresponding calculated oscillator (rotator) strengths. The 
spectra of the conformers were Boltzmann-weighted. The averaged spectra were normalized 
so that the height of the biggest peak be identical to that of the experimental spectra, 
furthermore, the spectra were shifted to longer wavelengths so that the position of the most 
intense band of the absorption spectra be identical. 
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